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Introduction
IgA de¢ciency is the most common primary immunoglobulin de¢ciency in many ethnic populations. The prevalence in Caucasians is approximately one in 500. Primary IgA de¢ciency is caused by a defect of terminal lymphocyte di¡erentiation, which leads to underproduction of serum and mucosal IgA; a¡ected individuals have normal IgA genes. Most individuals with IgA de¢ciency are deemed to be clinically asymptomatic. Those with symptoms of immunode¢ciency have predominantly sinopulmonary or gastrointestinal infections, which are more severe when there is associated IgG2/ IgG4 or IgG4 subclass or speci¢c antibody de¢ciency. There is an increased incidence of autoimmunity and, possibly, atopy in IgA de¢ciency.
IgA de¢ciency is a relatively common ¢nding in laboratories which routinely measure immunoglobulins. In this large immunology laboratory in a tertiary referral hospital, approximately one in 35 samples assayed for immunoglobulins are IgA de¢cient (IgAo0.06 g/L: adult reference range 0.8--4.0 g/L). After exclusion of samples from patients with haematological malignancy and those from patients with known IgA/IgG de¢ciency having intravenous IgG therapy, the incidence of selective IgA de¢ciency (i.e. IgAo0.06 g/L, but normal concentrations of IgG and IgM) is approximately one in 100. Although selective IgA de¢ciency can be primary (i.e. genetically determined) or secondary (due to the e¡ects of drugs or the result of other diseases), primary IgA de¢ciency appears to be the most commonly encountered form. Indeed, the terms IgA de¢ciency and selective IgA de¢ciency are often used to mean primary IgA de¢ciency. Unless otherwise stated, this review concerns primary IgA de¢ciency.
Though relatively common, the ¢nding of selective IgA de¢ciency is seldom of major immediate concern. However, it does raise the possibility that there might be impaired ability to deal with infection or, more likely, that there might be an undiagnosed autoimmune disease. Young women told of IgA de¢ciency may seek reassurance about the e¡ects on breast-feeding. Arguably, the most important concern in IgA de¢ciency is the reported adverse reaction to blood products which occur as a result of the production of anti-IgA antibodies in these patients.
Immunobiology
IgA is by far the most abundant immunoglobulin in non-de¢cient individuals, most of it found in mucosal secretions. There are two subclasses, IgA1 and IgA2, which di¡er by the absence of a 13-amino-acid sequence in the hinge region of the IgA2 molecule. IgA2 exists in two allotypic (genetic) variants --IgA2m(1) and IgA2m (2) , which di¡er in the points of attachment between heavy and light chains. IgA1 is the predominant subclass (90%) in serum, whereas IgA1 and IgA2 are found at similar concentrations in many secretions. 1, 2 Production IgA-bearing B cells ¢rst appear about three months after birth, whereas those bearing IgG and IgM appear earlier in development. 3 While both IgM and IgG plasma cells can usually be found by early second trimester, IgA-producing cells have not been observed before the 32nd week of pregnancy. 4 Serum IgA is usually undetectable at birth, and adult serum concentrations are not attained until around the time of puberty. In adults, the majority of human plasma cells produce IgA. More IgA is produced than all other immunoglobulin isotypes combined. 5
Plasma immunoglobulin A
Plasma IgA is produced by B lymphocytes in the bone marrow and in some peripheral lymphoid organs. 6, 7 In the plasma, IgA constitutes about 20% of the total Ig pool and it exists mainly as monomeric IgA1, (with a minor percentage of polymeric IgA (pIgA). Plasma IgA has a half-life of 3--6 days compared with a half-life of 21 days for IgG. Since the plasma concentration of IgA is approximately one-¢fth of that of IgG, this implies that the rates of synthesis of plasma IgG and IgA are similar. The function of plasma IgA antibodies remains unclear although it is recognized that aggregated IgA can e⁄ciently trigger in£ammatory cells through IgA Fc receptors, FcaRI, CD89. 8
Secretory immunoglobulin A
In secretions such as saliva, tears, colostrum, gastrointestinal £uids, nasal bronchial secretions and urine, the IgA is a polymeric (pIgA), predominantly dimeric IgA. Polymerization is dependent on the presence of an additional polypeptide termed 'J chain'. The IgA and J chain are produced by lymphocytes in organized germinal centres of mucosal-associated lymphoid tissues (MALT) such as Peyer's patches. The IgA produced by these lymphocytes binds to a membrane-associated polymeric Ig receptor (pIgR) on the baso-lateral side of mucosal epithelial cells 9 and then the complex is actively transported through the epithelial cell to the apical/luminal side. At this site, the bound IgA is released by proteolytic cleavage from the pIgR, generating the so-called secretory component, which remains associated with dimeric IgA, forming secretory IgA (SIgA). 10 SIgA plays a major role in preventing microorganisms and foreign proteins from penetrating the mucosal surfaces. 11 It also neutralizes toxins and infectious organisms. SIgA antibodies have been proposed to act primarily at the luminal side via a mechanism called immune exclusion. 12 However, other processes including intracellular interception of viral antigens during transepithelial IgA transport have been demonstrated. 13, 14 SIgA might also act at the stromal side, where IgA/Ag complexes can be eliminated by epithelial cell transcytosis 15 or by FcaR-bearing phagocytes. 16 Immunoglobulin A deficiency Selective IgA de¢ciency was initially described 17 in healthy individuals in 1963 and it has been extensively studied since then. Although most of the literature concerns primary IgA de¢ciency, it should be stressed there are other causes of selectively low concentrations or selective absence of IgA. These are discussed brie£y below. One important factor when considering reports on the selective IgA de¢ciency is its de¢nition, which has changed over the years, being in£uenced by the increasing sensitivity of the methods used to measure the IgA. Most laboratories now de¢ne de¢ciency as a serum IgA concentration o0.06 or 0.07 g/L: the concentration below which nephelometry becomes unreliable.
Primary (selective or isolated) immunoglobulin A deficiency
Patients are usually diagnosed with selective IgA de¢ciency based on the laboratory measurement of serum IgA concentration. The clinical presentation is not necessarily taken into consideration. The consensus of the Pan-American Group for Immunode¢ciency (PAGID) and the European Society for Immunode¢ciency (ESID) is that a de¢nitive diagnosis of (selective) IgA de¢ciency can be made in a male or female patient more than four years of age who has a serum IgA of less than 7 mg/dL (0.07 g/L) but normal serum IgG and IgM, in whom other causes of hypogammaglobulinaemia have been excluded ( Table 1) . By their de¢nition, these patients have a normal IgG antibody response to vaccination. 18 
Partial immunoglobulin A deficiency
Patients may be identi¢ed as those who have low serum IgA concentration for their age, and are thus categorized as having 'partial de¢ciency', 'subnormal concentrations' or as having 'probable' IgA de¢ciency. These are male or female patients more than four years of age who have serum IgA concentrations at least two standard deviations below mean normal concentrations for their age, but normal concentrations of IgG and IgM and in whom other causes of hypogammaglobulinaemia have been excluded. Patients with partial de¢ciency are more likely to undergo spontaneous remission than those with selective IgA de¢ciency. 19 Those in whom the normal concentrations do not return can have variable natural history. In some cases, the partial de¢ciency is due to selective IgA1 or IgA2 subclass de¢ciency.
Acquired or secondary immunoglobulin A deficiency
IgA de¢ciency can be caused by the e¡ects of various drugs (see later section) but this is usually reversible. Infections such as congenital rubella, hepatitis C and Epstein--Barr virus (EBV) on the other hand may cause persistent IgA de¢ciency. 20 In one case report, IgA de¢ciency was acquired in a recipient from an IgA-de¢cient donor after bone marrow transplantation. 21 
Transient immunoglobulin A deficiency
While most adult patients with IgA de¢ciency are considered to have a permanent condition, 22 very occasionally, some undergo spontaneous remission. 23 In contrast, delayed production of IgA in children is not uncommon and age-related concentrations of IgA should be treated with caution. 24 Immunoglobulin A subclass deficiency Several case reports have described IgA subclass de¢ciencies in symptomatic patients. 25 In apparently healthy blood donors, the selective absence of either IgA1 or IgA2 is more common than de¢ciency of total IgA. 26 
Pathophysiology of primary immunoglobulin A deficiency
Primary IgA de¢ciency is an immunode¢ciency presumed to result from a failure of terminal di¡erentiation in IgA-positive B cells. Many di¡erent mechanisms have been proposed. 27, 28 In patients with primary IgA de¢ciency, the secretory component appears to be intact, suggesting that the epithelial transport mechanism of IgA across enterocytes is relatively normal. 29 There is a paucity of IgA-bearing plasma cells of the gastrointestinal tract, and the substitution of IgM-or IgG-bearing plasma cells instead, which are activated on antigen challenge. 30 In the peripheral circulation, the number of IgA-bearing cells is decreased 31 with an immature phenotype, i.e. IgA-bearing B cells that are also positive for IgM and IgD. Why most individuals with primary IgA de¢ciency remain asymptomatic is still a mystery. The evidence that there are speci¢c compensatory mechanisms, which allow these individuals to remain healthy, is not entirely conclusive. A compensatory increase in secretory IgM in saliva and gastrointestinal £uid, as well as an increase in IgM-bearing plasma cells in gastrointestinal mucosa is found in subjects with primary IgA de¢ciency. 32 However, in one study, there appeared to be no correlation between salivary IgM in healthy and symptomatic IgA de¢ciency patients. 33, 34 There is evidence that infections are more common in individuals with primary IgA de¢ciency and low secretory IgM and it does appear that the mucosal IgM antibodies of IgA-de¢cient individuals eliminate viruses less e⁄ciently than the IgA antibodies of normal individuals. 35 It is possible that the IgG, which is found in all secretions, might play a more important role in IgA de¢ciency. 36 Although it is well documented that there is a lack of IgA in milk from mothers with IgA de¢ciency, often compensated for by raised IgG and IgM, there is surprisingly little published information on breast feeding in IgA de¢ciency.
Prevalence of primary immunoglobulin A deficiency
The prevalence of primary IgA de¢ciency varies markedly in di¡erent populations, whether measured within the community, in samples submitted to hospital laboratories or in samples from healthy blood donors. The prevalence in samples submitted to hospital laboratories is generally higher than in the population as a whole. 37, 38 The prevalence varies in di¡erent racial groups in the same geographical area. Among healthy blood donors, the prevalence ranges from one in 328--633 for those of European ancestry 39--41 to one in 5000 in China and one in 18,500 in Japan 42 and is even lower in India. 43 As stated earlier, some studies must be treated with caution because of di¡erences in the serum IgA concentration used to establish the diagnosis of IgA de¢ciency. This may range from 0.05 to 0.10 g/L, with many quoting 0.07 g/L probably because in many laboratories this concentration is the lowest detectable limit. 44 
Genetics of primary immunoglobulin A deficiency
Most cases of IgA de¢ciency appear to be sporadic. However, many familial cases have been described. 45 IgA de¢ciency has been considered to represent the mild manifestation of a spectrum of primary defects with common variable immunode¢ciency (CVID) the most severe. 46 In multiple-case families with dominant transmission of CVID and IgA de¢ciency, CVID was usually present in parents, with IgA de¢ciency in the descendents. A predisposing locus, designated IGAD1, found in the major histocompatibility complex (MHC) has been identi¢ed 47 and the occurrence of IgA de¢ciency in o¡spring is related to the gender of the a¡ected parent; a¡ected mothers were more likely to produce o¡spring with IgA de¢ciency than a¡ected fathers. Carrier mothers but not carrier fathers appear to transmit the IGAD1 alleles more frequently to the a¡ected o¡spring than would be expected under random segregation.
Association with major histocompatibility complex
Studies have shown association of certain HLA types with IgA de¢ciency in di¡erent ethnic populations. These 'susceptibility' haplotypes include HLA-A1, HLA-B8 and HLA-DR3, and HLA-A1, HLA-A29, HLA-B8 and HLA-B14. 48, 49 In contrast, certain haplotypes show 'protective' properties that decrease the risk of developing IgA de¢ciency. 50 Other genes in the region of the MHC have been investigated in IgA de¢ciency, such as tumour necrosis factor (TNF) polymorphisms. The MHC class III genes encoding complements C2, C4A and C4B and 21hydroxylase have also been studied in patients with IgA de¢ciency or CVID. 51 These studies suggest that a susceptibility gene or genes for both immunode¢ciencies are located within the class III region of the MHC, possibly between the C4B and C2 genes. Recent studies have linked IgA de¢ciency with genes outside the MHC. 52, 53 
Disease associations of primary immunoglobulin A deficiency
There are many diseases reported in association with IgA de¢ciency. These include autoimmune diseases, atopy and malignancies. Care must be taken assessing the signi¢cance of these associations because of the relative high frequency of IgA de¢ciency. The HLA haplotypes associated with various autoimmune diseases may coincidentally be similar to those in individuals with IgA de¢ciency and thus not necessarily re£ect a true association. The published associations might be useful in seeking underlying pathology in the unwell who are shown to be IgA de¢cient, but they pose questions when dealing with subjects who are IgA de¢cient, but otherwise healthy.
Autoimmune diseases
A number of autoimmune diseases have been associated with primary IgA de¢ciency ( Table 2 ). The serum samples of IgA-de¢cient subjects not exhibiting any autoimmune disease often contain autoantibodies. 54, 55 A common feature of IgA de¢ciency is the occurrence of increased concentrations of serum antibodies to cow's milk proteins and other proteins of bovine origin. 56 It has been found that patients with IgA de¢ciency and high titres of antibodies to cow's milk are also more likely to have other autoantibodies. This suggests that IgA-de¢cient subjects with anti-food antibodies may have enhanced gastrointestinal antigen absorption and that food-derived antigens might cross-react with self-antigens. Molecular mimicry of gut microbial antigens could also play a part.
Patients with coeliac disease (CD) have a high incidence of IgA de¢ciency. Reports suggest a prevalence of one in 200 or even higher. 57--58 These patients lack the characteristic IgA anti-endomysial or anti-tissue transglutaminase antibodies used in diagnosis of CD which might lead to an underestimation of the prevalence. 59 In one review of patients with CD, 60 3.3% had IgA de¢ciency and these responded to a gluten-free diet in a similar fashion to those without IgA de¢ciency. The intestinal biopsy specimens of patients with coexisting IgA de¢ciency and CD are similar to those of patients with CD alone. 61 IgA concentrations should always be measured at the same time as serology for CD. The increased use of enzyme-linked immunoassays (ELI-SAs) for the detection of IgA antibodies against tissue transglutaminase provides the possibility of detection of IgA de¢ciency since de¢cient patients can give lower than background readings in the assays. This may further increase the detection rate of IgA de¢ciency in this group of patients. 62 The possibility of CD should always be considered in patients identi¢ed as having IgA de¢ciency and exhibiting any symptoms. Diagnosis of CD in IgA de¢ciency requires measurement of IgG anti-endomysial or anti-tissue transglutaminase antibodies and/or duodenal biopsy. 62 Allergy IgA de¢ciency has long been associated with the development of allergy although the evidence is not conclusive. In blood donors with incidental ¢ndings of IgA de¢ciency, allergy has been shown to be more common (20%) than in blood donors with normal concentrations of IgA (10%). 63 IgE concentrations are often increased in IgA de¢ciency. 64 The most common allergic disorders reported are allergic conjunctivitis, rhinitis, urticaria, atopic eczema and bronchial asthma. 65 Food allergy may be more common in IgA de¢ciency. However, others have reported no association between IgA de¢ciency and atopy of childhood. 66 
Malignancies
Carcinoma (particularly adenocarcinoma of the stomach) and lymphoma (usually of B-cell origin) may be associated with IgA de¢ciency. 67 The lymphomas are usually extranodal and involve the jejunum. Nodular lymphoid hyperplasia, probably the most common intestinal abnormality in IgA de¢ciency, is thought generally not to lead to lymphoma. In one early study 68 it was found that IgA de¢ciency was more common than expected in cancer patients (incidence of 0.3%). However, in a later, more extensive study, patients with IgA de¢ciency were shown not to have a higher overall incidence of cancer. More IgA-de¢cient patients did have stomach cancer, but this was not statistically signi¢cant. There was also no increase in lymphoid malignancy. 69 In case reports, other cancers found in patients with selective IgA de¢ciency are carcinoma of the colon, ovarian cancer, lymphosarcoma, melanoma and thymoma. 69 
Infections
Recurrent sinopulmonary infections are the most common illnesses associated with selective IgA de¢ciency. This probably explains the rationale of checking immunoglobulin concentrations when assessing these patients. The frequency of these infections varies. Most infections are caused by minor bacterial pathogens or, in the absence of exact bacteriologic diagnosis, various viral agents. Infections are more likely to occur in IgA de¢ciency associated with IgG2 subclass de¢ciency. 70 There are several reports of chronic serious lung disease in selective IgA de¢ciency, including bronchiectasis. 71 The incidence of serious recurrent infection in only a minority of individuals with IgA de¢ciency has led to the search for a second common immunode¢ciency, which, in these patients, might have a synergistic e¡ect. De¢ciency of mannan-binding lectin (MBL) is one possibility since the frequency is approximately 6% in the populations where IgA de¢ciency is common. However, MBL de¢ciency was not found to correlate with increased number of illnesses in IgA-de¢cient individuals. 70 Patients with IgA de¢ciency have an increased frequency of gastrointestinal infections. The best-known association is infection with Giardia lamblia. Presumably the lack of SIgA permits the attachment and proliferation of these protozoa on the intestinal epithelium. 72 This may result in malabsorption, and is often accompanied by nodular lymphoid hyperplasia.
Other primary immunodeficiencies
IgA de¢ciency may occur as part of a more complex picture of immunode¢ciency. This is particularly the case with common variable immunode¢ciency. Some of the other immunode¢ciencies associated with a lack of IgA are listed in Table 3 .
Immunoglobulin A deficiency caused by prescribed drugs
Drugs are well known to cause IgA de¢ciency, sometimes associated with more extensive hypogammaglobulinaemia. The loss of IgA tends to be reversible on withdrawal of the drugs (Table 1) . Anti-convulsants, non-steroidal anti-in£ammatory drugs (NSAID) and disease-modifying anti-rheumatic drugs (DMARD) are the more commonly prescribed drugs causing IgA de¢ciency. 73--75 The mechanisms by which anti-convulsants cause IgA de¢ciency might be similar to those in primary IgA de¢ciency. However in all of these cases, it may be debatable whether the disease being treated is associated with the IgA de¢ciency or the drug.
Management Investigations
The criteria for diagnosing IgA de¢ciency vary because the di¡erent methodologies for measuring serum IgA a¡ect the lower limit of detection. The more widely used methods of measuring serum IgA include nephe-lometry and radial immunodi¡usion (RID). Various other methods have been described in studies where blood donors are screened for IgA de¢ciency The lower limit of detection of serum IgA is 0.07 g/L for nephelometry, 0.05 g/L for low-concentration radial immuno-di¡usion plates and 0.0016 g/L for haemagglutination inhibition techniques. Almost all patients with IgA de¢ciency will have low or absent IgA1 and IgA2 in the mucosal secretions, but these are not routinely measured. Various assays have been used to detect anti-IgA antibodies which have been linked to transfusion reactions. However, there is no consensus on whether or not these assays are necessary (see below). Other immunological tests may be necessary depending on the clinical presentation of the patients. These include measuring IgG subclasses, speci¢c IgE allergens and autoantibodies.
Treatment
There is no speci¢c treatment for patients with symptomatic IgA de¢ciency. Antibiotics are prescribed in those with acute infections. Patients with sino-pulmonary infections are treated according to local treatment protocols used for community-acquired respiratory infections in non-IgA-de¢cient individuals. Those with recurrent respiratory infections may be prescribed prophylactic antibiotics. The choice would vary among various hospital centres and there is no consensus guideline on this.
In those not responding to prophylactic antibiotics, there is a role for the use of immunoglobulin therapy. 76 Previously, prophylactic intravenous immunoglobulin therapy was contraindicated in patients with IgA de¢ciency because of the risk of a severe systemic adverse reaction, or the development of anti-IgA antibodies. Reports now indicate safe and e¡ective therapy in this group of patients requiring immunoglobulin therapy (including the subcutaneous route), including those with anti-IgA antibodies. 76, 77 Prognosis Selective IgA de¢ciency is the mildest form of primary antibody de¢ciency. In long-term follow up studies of blood donors with IgA de¢ciency, the defect was shown to be permanent in all cases. The majority of individuals did experience various infections and in some cases drug allergy, or autoimmune or atopic disease. 78 
Anti-immunoglobulin A antibodies
A signi¢cant proportion of IgA-de¢cient individuals are reported to have anti-IgA antibodies in their serum. 79--81 Although blood or blood products given to IgA-de¢cient individuals with high titres of anti-IgA antibodies can lead to severe, even fatal, transfusion reactions, such reactions are quite rare. Hospitalized patients, some of whom are certain to be IgA de¢cient, are usually not screened for anti-IgA antibodies prior to blood transfusions. The actual incidence of anti-IgAmediated blood infusion reactions due to anti-IgA antibodies has been estimated to be as low as1.3 per million units of blood or blood products infused, 82 although other studies suggest a higher incidence. 83 One study concluded that with respect to supplying IgA-de¢cient blood products, a cut-o¡ concentration of 0.5 mg/L should be the maximum permissible IgA concentration in order to ensure that no adverse reactions occur in individuals with class-speci¢c anti-IgA antibodies. 82 A number of assays have been developed to detect anti-IgA antibodies. 83 Most are indirect haemagglutination assays. The speci¢city of anti-IgA antibodies is not known. Some studies have suggested that titres of anti-IgA antibodies did not distinguish healthy IgA-de¢cient blood donors from those with a history of anaphylactic transfusion reaction. 84 Anti-IgA antibodies are usually of the IgG1 subclass and are more common in IgA-de¢cient subjects who are also IgG2 de¢cient. 80, 85 Anti-IgA antibodies may be of the IgE isotype leading to true anaphylactic reactions but the actual incidence of such antibodies is unknown. Anti-IgA antibodies are also possibly associated with certain HLA types in IgA-de¢cient healthy individuals. 86 Long-term follow-up of 159 healthy blood donors with selective IgA de¢ciency and 45 with partial IgA de¢ciency indicated that only those healthy adults who have severe IgA de¢ciency develop anti-IgA antibodies and their anti-IgA concentrations remain fairly constant. Of the159 subjects with severe IgA de¢ciency, 66 had a history of IgA exposure but no correlation to anti-IgA antibody development was noted. 87 
Conclusion
It remains a mystery why de¢ciency of what is arguably the most abundant molecule of a normal immune system should usually have such little e¡ect. Nevertheless, the increased frequency of IgA de¢ciency in samples submitted to hospital laboratories does suggest that it does have some e¡ects. It is not appropriate for laboratory reports showing the detection of IgA de¢ciency to be sent out without comment. Appropriate comments should be made based on clinical details if they are available or, if not, reports should contain a general comment about the association of increased incidence of infection at mucosal sites and autoimmunity. The association with CD is particularly important. It is another conundrum that while diagnostic laboratory tests for CD depend on the detection of IgA antibodies, CD is associated with IgA de¢ciency and can therefore be missed. The possibility of (rare) reactions to blood or blood products due to the presence of anti-IgA antibodies should also be commented upon. Finally, clinical biochemistry laboratories should be aware that IgA de¢ciency has been reported to interfere with the determination of beta human chorionic gonadotrophin (bHCG) in some assays. 88 
